Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.

Authors :: Attarbaschi A
Mann G
Zimmermann M
Bader P
Barisone E
Basso G
Biondi A
Cario G
Cazzaniga G
Colombini A
Flotho C
Kuhlen M
Lang P
Lauten M
Linderkamp C
Locatelli F
Lo Nigro L
Möricke A
Niggli F
Panzer-Grümayer R
Parasole R
Peters C
Caterina Putti M
Rizzari C
Suttorp M
Valsecchi MG
Conter V
Schrappe M
Source :: Leukemia [Leukemia] 2020 Jun; Vol. 34 (6), pp. 1694-1700. Date of Electronic Publication: 2019 Dec 05.
Publication Year :: 2020

Subjects :: Adolescent
Asparaginase administration & dosage
Child
Child, Preschool
Cyclophosphamide administration & dosage
Cytarabine administration & dosage
Daunorubicin administration & dosage
Female
Humans
Infant
Male
Mercaptopurine administration & dosage
Methotrexate administration & dosage
Prednisone administration & dosage
Time
Treatment Outcome
Vincristine administration & dosage
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy

Full Text Access

Tools